FDA approves AChEI ALPHA-1062 for Alzheimer’s disease treatment
On July 29, 2024, the U.S. FDA approved Alpha Cognition Inc.’s ALPHA-1062 (Zunveyl®), an Acetylcholinesterase (AChE) inhibitor, for treating mild-to-moderate
Read moreOn July 29, 2024, the U.S. FDA approved Alpha Cognition Inc.’s ALPHA-1062 (Zunveyl®), an Acetylcholinesterase (AChE) inhibitor, for treating mild-to-moderate
Read moreThree high-impact steps could be taken by global health leaders to reshape the global regulatory framework and help address the
Read moreDGIST (President Lee Kunwoo) Department of Brain Sciences Professor Lee Kwang and his team have discovered a new correlation between
Read moreIn a study published in Life Science Alliance, Texas A&M AgriLife Research scientists found that decreasing folate intake can support healthier metabolisms in
Read moreAcross process applications, maintenance teams are in a constant battle to maintain operational productivity and minimise downtime. Although maintenance team
Read moreAtlas Copco is expanding its Energy Storage Systems (ESS) range with the launch of the new ZBP 120-120 and ZBP
Read moreRemote healthcare delivery, commonly known as telehealth or telemedicine, is often beneficial for patients who have difficulty visiting their preferred
Read moreThe world of medical technology is constantly changing, and innovation is key. Wearable devices have become game-changers, allowing for continuous
Read moreResistance, or weight training, is widely recommended in sports and rehabilitation as an effective exercise to increase muscular strength and
Read moreAnnouncing a new article publication for BIO Integration journal. The emergence of infectious diseases, including viral zoonoses, has allowed intensive
Read more